Dr Lawrence Madiefsky, DPM | |
9753 Nw 33rd Street, Suite 201, Coral Springs, FL 33065 | |
(954) 341-8513 | |
(954) 341-8514 |
Full Name | Dr Lawrence Madiefsky |
---|---|
Gender | Male |
Speciality | Podiatry |
Experience | 41 Years |
Location | 9753 Nw 33rd Street, Coral Springs, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316032691 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213ES0103X | Podiatrist - Foot & Ankle Surgery | PO0001602 (Florida) | Primary |
Provider Name | Lawrence Madiefsky, Dpm, Pa |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1013281278 PECOS PAC ID: 1759540073 Enrollment ID: O20120306000718 |
News Archive
A new analysis of the Phase II Alzheimer's drug pipeline, conducted by ResearchersAgainstAlzheimer's, revealed 57 new Alzheimer's drugs. According to the analysis, nearly twice as many mechanisms of action are being tested in Phase II than in Phase III clinical trials.
GE Healthcare today announced the receipt of a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use. This opinion recommends the granting of a marketing authorisation for VIZAMYL (Flutemetamol F18 injection), a radiopharmaceutical medicinal product indicated for Positron Emission Tomography imaging of beta amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive impairment.
Arteriocyte, a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts announced today approval from the Food and Drug Administration (FDA) to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Compartment Syndrome.
The 39 independent Blue Cross and Blue Shield companies strongly support passing bipartisan comprehensive healthcare reform this year that will expand access to affordable coverage and rein in costs for everyone. We agree with the goal of the legislation to cover all Americans.
Exposure to chronic, low dose radiation — the conditions present in deep space — causes neural and behavioral impairments in mice, researchers report in eNeuro.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Lawrence Madiefsky, DPM 9753 Nw 33rd Street, Suite 201, Coral Springs, FL 33065-5795 Ph: (954) 341-8513 | Dr Lawrence Madiefsky, DPM 9753 Nw 33rd Street, Suite 201, Coral Springs, FL 33065 Ph: (954) 341-8513 |
News Archive
A new analysis of the Phase II Alzheimer's drug pipeline, conducted by ResearchersAgainstAlzheimer's, revealed 57 new Alzheimer's drugs. According to the analysis, nearly twice as many mechanisms of action are being tested in Phase II than in Phase III clinical trials.
GE Healthcare today announced the receipt of a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use. This opinion recommends the granting of a marketing authorisation for VIZAMYL (Flutemetamol F18 injection), a radiopharmaceutical medicinal product indicated for Positron Emission Tomography imaging of beta amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive impairment.
Arteriocyte, a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts announced today approval from the Food and Drug Administration (FDA) to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Compartment Syndrome.
The 39 independent Blue Cross and Blue Shield companies strongly support passing bipartisan comprehensive healthcare reform this year that will expand access to affordable coverage and rein in costs for everyone. We agree with the goal of the legislation to cover all Americans.
Exposure to chronic, low dose radiation — the conditions present in deep space — causes neural and behavioral impairments in mice, researchers report in eNeuro.
› Verified 6 days ago
Dr. Robert Samuel Nelson, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 8546 Nw 18th Pl, Coral Springs, FL 33071 Phone: 954-575-9456 Fax: 954-575-9456 | |
Yanick Beauvoir Maynard, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 7857 W Sample Rd Suite 157, Coral Springs, FL 33065 Phone: 954-775-0168 Fax: 954-757-7009 | |
Dr. Daniel Emerson Heck, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 473 Nw 94th Way, Coral Springs, FL 33071 Phone: 954-802-3153 | |
Iliya Beylin, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 7501 Wiles Rd, Suite 104, Coral Springs, FL 33067 Phone: 954-755-4994 Fax: 954-755-4995 | |
Dr Arthur B Korbel Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2901 Coral Hills Dr, Suite 220, Coral Springs, FL 33065 Phone: 954-753-3146 | |
Dr. Richard Gary Philips, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 936 Nw 127th Ave, Coral Springs, FL 33071 Phone: 954-345-9506 | |
Certified Foot & Ankle Specialists Podiatrist Medicare: Medicare Enrolled Practice Location: 817 Coral Ridge Dr, Coral Springs, FL 33071 Phone: 954-753-3030 Fax: 954-666-0410 |